Announcement on Results of Redemption at Maturity of "DaShenLin Convertible Bonds" and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Results of Redemption at Maturity of "DaShenLin Convertible Bonds" and Share Changes
Filed with SSE · Stock code 603233 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)DaShenLin Pharmaceutical Group Co., Ltd. on 6ix
Story so far
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Adjustment of the Conversion Price of "DaShenLin Convertible Bonds"
Earlier from DaShenLin Pharmaceutical
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Adjustment of the Conversion Price of "DaShenLin Convertible Bonds"
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
- (603233)"DaShenLin Pharmaceutical Group Co., Ltd."Indicative Announcement on Suspension of Conversion of "DaShenLin Convertible Bonds" During the Implementation of Dividend Distribution for the First Half of 2026
Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.
Follow DaShenLin Pharmaceutical